INDEPENDENT MEDICAL EXAMINATION SERVICE BUSINESS PLAN

I. Executive Summary

Company Description

MedSight Evaluations—named to convey clinical clarity and forward-looking insight—launches in 2026 as a U.S.-based provider of Independent Medical Examinations (IMEs) and medical-legal evaluations. We operate in the insurance and legal services sector, connecting insurance carriers, law firms, and large employers with a national network of board-certified medical specialists. Our core services are scheduled and peer-review IMEs, specialty consults, and digital case management, delivered through a proprietary platform that prioritizes speed, security, and clinical accuracy. One-liner: We turn complex medical claims into decisive, defensible reports quickly and securely.

We run intake, scheduling, clinician matching, telehealth and in-person examinations, report drafting, and secure delivery, supported by quality review and chain-of-custody documentation. What sets us apart is our technology-enabled logistics, national specialist network, and standardized clinical QA that reduce turnaround by 30% versus legacy providers while improving defensibility. Target customers are mid-to-large regional insurance carriers, plaintiffs and defense law firms, and workers’ compensation programs. Short-term goal: achieve national operations and 50 enterprise clients by end-2027. Long-term goal: scale to 300 enterprise clients and expand into forensic imaging and AI-assisted triage by 2030.

Problem

Complex medical uncertainty in workers' compensation and liability claims creates prolonged claim timelines, higher litigation costs, and volatile reserve estimates. Ambiguous records, conflicting expert opinions, and disputed causation or impairment force repeated reviews and depositions, delaying settlements and increasing legal spend.

Current expert sourcing is fragmented across vendors and individual experts, which reduces consistency, slows response times, and makes it hard for carriers and law firms to get rapid, objective answers. There is no centralized, evidence-based source for rapid, objective medical evaluations tailored to high-stakes claims.

Solution

Stakeholders face disputed, ambiguous medical claims that cause costly delays and uncertain outcomes; our service addresses this by connecting a national network of board-certified specialists in Orthopedic Surgery, Neurology, and Pain Management to cases via a secure digital platform that schedules exams, collects standardized clinical data and imaging, and delivers defensible medical reports—peer-reviewed, date-stamped, and evidence-linked—to authorized parties for timely, objective claim resolution.

Objective medical findings that support fair, timely resolution.

Mission Statement

We deliver unwavering medical clarity and objective evidence to the insurance and legal industries by combining clinical excellence with practical technological innovation. We act as a trusted partner for Independent Medical Examinations, providing timely, defensible, and high-quality evaluations that support fair resolutions. We maintain the highest standards of integrity and professionalism so clients get the medical insights they need to navigate complex claims with confidence.

Key Success Factors

These are the core factors that will drive the Independent Medical Examination service's performance and defensibility.

• Network scale: grow and maintain a board-certified specialist network of 255 practitioners by 2030.
• Proprietary platform: secure, user-friendly technology that increases client retention and operational efficiency.
• Experienced leadership: Medical Director and CEO with deep U.S. healthcare and insurance market expertise.
• Immediate profitability: achieve one-month breakeven to fund reinvestment and ensure financial stability.
• Rigorous quality assurance: consistently produce legally defensible reports that set the market standard.

Financial Summary

Financial summary for the Executive Summary: five-year forecast shows rapid scaling and strong returns.

Financial requirements: Minimum cash required $796,000 (Feb-26); initial CapEx total $630,000. Anticipated ROI: IRR 32.85% and ROE 85.74%.

Outlook: breakeven and payback in month 1 with sustained EBITDA growth to $40,311,000 by 2030.

Funding Requirements

We require USD 1,421,000 on Day 1 to cover capital expenditures and a minimum cash buffer for launch and the initial 50-physician network.

Financials: Year 1 revenue USD 3,714,000 rising to USD 53,591,000 by 2030; EBITDA grows from USD 1,540,000 to USD 40,311,000; IRR 32.85% and ROE 85.74% — breakeven and payback occur within the first month.